BETAHISTINE 16mg. IP

An antivertigo drug that is used in the management of vertigo and vestibular pathologies of different aetiologies. (Lacour, 2013) Significantly effective in preventing/reversing the hearing deterioration in patients with Meniere’s disease. (Seyed Javad Seyed Tootoonchi, 2016) Exerts a positive effect in terms of reduction in vertigo symptoms. (Louisa Murdin K. H., 2016) An effective therapy for Meniere’s disease and related conditions. (Van Esch B, 2020) Improves the symptoms related to Meniere’s disease, such as vertigo sensation. Effectively reduces the pressure and ameliorates the blood flow to certain areas within the inner ear. (Deborah A Hall, 2018) Reduces the frequency and severity of vertiginous episodes, hearing loss, and tinnitus. (Cochrane ENT Group, 2001) Arrests the progression of hearing loss in patients with Meniere’s syndrome. (Cochrane ENT Group, 2001) An effective and safe option for the treatment of peripheral vertigo. (Rubén Ramos Alcocer, 2015)